rs1406

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001238.4(CCNE1):​c.*428C>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.265 in 249,640 control chromosomes in the GnomAD database, including 9,380 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.28 ( 6188 hom., cov: 32)
Exomes 𝑓: 0.25 ( 3192 hom. )

Consequence

CCNE1
NM_001238.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0800

Publications

23 publications found
Variant links:
Genes affected
CCNE1 (HGNC:1589): (cyclin E1) The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK2, whose activity is required for cell cycle G1/S transition. This protein accumulates at the G1-S phase boundary and is degraded as cells progress through S phase. Overexpression of this gene has been observed in many tumors, which results in chromosome instability, and thus may contribute to tumorigenesis. This protein was found to associate with, and be involved in, the phosphorylation of NPAT protein (nuclear protein mapped to the ATM locus), which participates in cell-cycle regulated histone gene expression and plays a critical role in promoting cell-cycle progression in the absence of pRB. [provided by RefSeq, Apr 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.4 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCNE1NM_001238.4 linkc.*428C>A 3_prime_UTR_variant Exon 12 of 12 ENST00000262643.8 NP_001229.1 P24864-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCNE1ENST00000262643.8 linkc.*428C>A 3_prime_UTR_variant Exon 12 of 12 1 NM_001238.4 ENSP00000262643.3 P24864-1

Frequencies

GnomAD3 genomes
AF:
0.278
AC:
42209
AN:
151890
Hom.:
6172
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.331
Gnomad AMI
AF:
0.351
Gnomad AMR
AF:
0.346
Gnomad ASJ
AF:
0.164
Gnomad EAS
AF:
0.374
Gnomad SAS
AF:
0.415
Gnomad FIN
AF:
0.251
Gnomad MID
AF:
0.177
Gnomad NFE
AF:
0.224
Gnomad OTH
AF:
0.248
GnomAD4 exome
AF:
0.246
AC:
23971
AN:
97632
Hom.:
3192
Cov.:
0
AF XY:
0.243
AC XY:
11214
AN XY:
46084
show subpopulations
African (AFR)
AF:
0.323
AC:
1409
AN:
4360
American (AMR)
AF:
0.345
AC:
1083
AN:
3136
Ashkenazi Jewish (ASJ)
AF:
0.163
AC:
896
AN:
5512
East Asian (EAS)
AF:
0.394
AC:
4819
AN:
12224
South Asian (SAS)
AF:
0.425
AC:
423
AN:
996
European-Finnish (FIN)
AF:
0.246
AC:
490
AN:
1990
Middle Eastern (MID)
AF:
0.142
AC:
80
AN:
564
European-Non Finnish (NFE)
AF:
0.211
AC:
12924
AN:
61152
Other (OTH)
AF:
0.240
AC:
1847
AN:
7698
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
861
1722
2582
3443
4304
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.278
AC:
42243
AN:
152008
Hom.:
6188
Cov.:
32
AF XY:
0.284
AC XY:
21095
AN XY:
74288
show subpopulations
African (AFR)
AF:
0.330
AC:
13684
AN:
41430
American (AMR)
AF:
0.346
AC:
5285
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.164
AC:
571
AN:
3472
East Asian (EAS)
AF:
0.374
AC:
1929
AN:
5164
South Asian (SAS)
AF:
0.415
AC:
2000
AN:
4822
European-Finnish (FIN)
AF:
0.251
AC:
2655
AN:
10566
Middle Eastern (MID)
AF:
0.173
AC:
51
AN:
294
European-Non Finnish (NFE)
AF:
0.224
AC:
15212
AN:
67958
Other (OTH)
AF:
0.255
AC:
539
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
1500
3000
4501
6001
7501
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
434
868
1302
1736
2170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.241
Hom.:
14894
Bravo
AF:
0.282
Asia WGS
AF:
0.448
AC:
1557
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
5.0
DANN
Benign
0.48
PhyloP100
0.080
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1406; hg19: chr19-30315112; API